Author details

Full Name

William D Thomas

Affiliation

ORCID

Career Start Year

1989

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
33861525	Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.	New England Journal of Medicine	2021
29866909	Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection.	Infection and Immunity	2018
30459206	Correction for Giuntini et al., "Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection".	Infection and Immunity	2018
27859766	Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions.	J Mol Recognit	2017
28794021	Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope.	J Virol	2017
27338767	Pre-exposure Prophylaxis With OspA-Specific Human Monoclonal Antibodies Protects Mice Against Tick Transmission of Lyme Disease Spirochetes.	Journal of Infectious Diseases	2016
26018774	A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life.	mAbs	2015
25484044	Resolving self-association of a therapeutic antibody by formulation optimization and molecular approaches.	MAbs	2014
23940209	Identification of a human monoclonal antibody to replace equine diphtheria antitoxin for treatment of diphtheria intoxication.	Infection and Immunity	2013
23995619	Analytical characterization of a monoclonal antibody therapeutic reveals a three-light chain species that is efficiently removed using hydrophobic interaction chromatography.	mAbs	2013
20089970	Treatment with monoclonal antibodies against Clostridium difficile toxins.	New England Journal of Medicine	2010
19759151	Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus.	Journal of Virology	2009
17240489	Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates.	Vaccine	2007
16453264	Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters.	Journal of Infectious Diseases	2006
16966409	Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.	Infection and Immunity	2006
15655773	Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice.	J Infect Dis	2005
15078936	Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.	Journal of Virology	2004
15496474	CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.	Proc Natl Acad Sci U S A	2004
12713285	Parallel synthesis of glycomimetic libraries: targeting a C-type lectin.	Org Lett	2003
12785845	Surface plasmon resonance imaging studies of protein-carbohydrate interactions.	J Am Chem Soc	2003
11159994	Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults.	Infection and Immunity	2001
10768972	Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.	Infection and Immunity	2000
9916055	Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.	Infection and Immunity	1999
7797906	Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.	Journal of Infectious Diseases	1995
7890380	Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis.	Infect Immun	1995
7890401	Urease-specific monoclonal antibodies prevent Helicobacter felis infection in mice.	Infection and Immunity	1995
1400227	A heterologous membrane protein domain fused to the C-terminal ATP-binding domain of HlyB can export Escherichia coli hemolysin.	Journal of Bacteriology	1992
1615065	Mobilization of recombinant plasmids from Staphylococcus aureus into coagulase negative Staphylococcus species.	Plasmid	1992
1419112	The synthesis and function of the Escherichia coli hemolysin and related RTX exotoxins.		1992
2552907	Mobility of gentamicin resistance genes from staphylococci isolated in the United States: identification of Tn4031, a gentamicin resistance transposon from Staphylococcus epidermidis.	Antimicrobial Agents and Chemotherapy	1989
2644233	Identification and cloning of the conjugative transfer region of Staphylococcus aureus plasmid pGO1.	Journal of Bacteriology	1989